// App-Quantinova.ai

: Prognostic Value of Cpss Cytogenetic Risk Classification in Patients with CMML after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Multicenter Study of the Chronic Malignancies Working Party of the EBMT

Researchers

Presenter

  • Christian Koenecke

Principal Investigators

  • Sheree Hazelaar

  • Dietrich W. Beelen

  • Victoria Potter

  • Martin Bornhaeuser

  • Nicolaus Krger

  • Jrgen Finke

  • Dietger Niederwieser

  • Peter Dreger

  • Yves Chalandon

  • Arnold Ganser

  • Johan Maertens

  • Noel Milpied

  • Guido Kobbe

  • Maija Itl-Remes

  • Henrik Sengeloev

  • Gerard Socie

  • Per Ljungman

  • Didier Blaise

  • Ellen Meijer

  • Hendrik Veelken

  • Francesco Onida

  • Marie Robin

  • Ibrahim Yakoub-Agha

Medical Centers

  • Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hematology, Hemostasis, Oncology and SCT, Hannover, Germany

  • EBMT Statistical Unit,Leiden,Netherlands

  • EBMT Data Office Leiden,, Leiden,, Netherlands

  • Department of Bone Marrow Transplantation, University Hospital, Essen,

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

  • Universitatsklinikum Cad GustavCarus an der Technischen Universltat Dresden, Dresden, DEU

  • Department of Stem Cell Transplantation, University Medical Center Hamburg, Hamburg,

  • Department of Hematology, Oncology and Stem Cell Transplantation, Uniklinik Freiburg, Freiburg, Germany

  • Dept. Hematology and Cell Therapy,University Hospital Leipzig,Leipzig,Germania

  • Dept. of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

  • Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • Department of Hematology, University Hospital Gasthuisberg, Dept. of Hematology, Leuven, Belgium

  • Hématologie Clinique et Thérapie cellulaire, CHU Bordeaux, Bordeaux, France

  • Deptartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany

  • HUCH Comprehensive Cancer Center, Stem Cell Transplantation Unit,Helsinki,Finland

  • Department of Hematology, University Hospital Rigshospitalet, Copenhagen, Denmark

  • Bone-marrow transplantation department, CHU Saint-Louis, Paris, France

  • Department of Oncology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

  • Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France

  • VU University Medical Center, Amsterdam, Netherlands

  • Department of Urology, Leiden Unviersity Medical Center, Leiden, Netherlands

  • Endocrinology Unit, Foundation IRCCS CaÂ’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy

  • Hematology/Transplantation, Hospital Saint Louis, Paris, France

  • CHU de Lille, LIRIC, INSERM U995, Université de Lille, France, Lille, France

Locations

  • Germany

  • Netherlands

  • United Kingdom

  • Switzerland

  • Belgium

  • France

  • Finland

  • Denmark

  • Sweden

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic myelomonocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved